IPO GMP Today: Vishal Mega Mart vs MobiKwik vs Sai Lifesciences - Subscription updates, other key details

The latest GMPs of Vishal Mega Mart, One MobiKwik and Sai Life Sciences signal varied listing expectations

Three mainboard IPOs are in their second day of bidding today. All three received encouraging subscriptions yesterday, but their varied GMPs indicate different listing expectations.

Vishal Mega Mart's mega Rs 8,000-crore public issue has already been subscribed more than half, receiving 51 percent subscription on December 11, with a robust GMP (grey market premium) fueling hopes of potential listing gains.

Vishal Mega Mart IPO will conclude on December 13. Shares are available in the price band of Rs 74-78 apiece, with a lot size of 190 shares.

In the grey market the shares of the company are trading at a premium of about 30 percent. Investorgain quoted a GMP of Rs 22 on Vishal Mega Mart shares in the unofficial market, indicating a listing gain of over 28 percent.

Vishal Mega Mart IPO subscription status: Issue booked 51% on Day 1; Retail, NII lead

The initial public offering (IPO) of fintech company One MobiKwik Systems got fully subscribed within an hour of opening of the issue on Wednesday. One MobiKwik Systems on Tuesday said it garnered Rs 257 crore from anchor investors. The Rs 572-crore IPO is available for public subscription during December 11 to 13.

The issue got subscribed 7.31 times on the first day of share sale on Wednesday. The share sale received bids for 8.67 crore shares against 1.18 crore shares on offer, as per NSE data. The company has fixed the price band of Rs 265-279 per share.

As for the GMP, the shares of the company are trading at a premium of about 50 percent. MobiKwik shares are proposed to be listed on both NSE and BSE on December 18 (Wednesday).

MobiKwik IPO subscribed 7.31 times on Day 1; retail portion booked nearly 26x

The IPO of Sai Life Sciences, which is backed by the global private equity major TPG Capital, was off to a decent start on December 11, the first day of subscription, as the issue was subscribed 84 percent. Stock exchange data showed that investors bid for 3.27 crore shares as against 3.88 crore shares on offer.

However, Sai Life Sciences' shares have a modest GMP of 7 percent in the unofficial market, according to Investorgain. The share listing for all the three mainboard issues is proposed to be held on both NSE and BSE on December 18.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.